OGN Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
1.6B
+1.0%
1.6B
+6.7%
1.5B
-3.1%
1.5B
-5.9%
1.6B
Cost of Revenue
705.0M
-0.8%
711.0M
+5.0%
677.0M
-11.6%
766.0M
+2.8%
745.0M
Gross Profit
869.0M
+2.6%
847.0M
+8.2%
783.0M
+5.7%
741.0M
-13.5%
857.0M
Operating Expenses
504.0M
-4.0%
525.0M
-4.2%
548.0M
-34.1%
832.0M
+66.7%
499.0M
R&D
83.0M
-8.8%
91.0M
-2.2%
93.0M
+2.2%
91.0M
+8.3%
84.0M
SG&A
421.0M
-3.0%
434.0M
+2.4%
424.0M
-2.1%
433.0M
+4.3%
415.0M
Operating Income
365.0M
+13.4%
322.0M
+37.0%
235.0M
+358.2%
-91000000
-125.4%
358.0M
EBITDA
447.0M
+11.2%
402.0M
+14.2%
352.0M
+12.5%
313.0M
-30.4%
450.0M
Net Income
164.0M
+51.9%
108.0M
-26.0%
146.0M
+171.2%
-205000000
-228.1%
160.0M
EPS (Basic)
$0.62
+51.2%
$0.41
-26.8%
$0.56
+170.9%
$-0.79
-229.5%
$0.61
EPS (Diluted)
$0.60
+50.0%
$0.40
-27.3%
$0.55
+170.5%
$-0.78
-227.9%
$0.61
Shares (Diluted)
272.4M
+0.7%
270.4M
+2.9%
262.9M
+0.6%
261.2M
+0.2%
260.7M
Organon & (OGN) — Financials